TY - JOUR
T1 - Role of vitamin D3 receptor in the synergistic differentiation of WEHI- 3B leukemia cells by vitamin D3 and retinoic acid
AU - Li, Jianming
AU - Finch, Rick A.
AU - Sartorelli, Alan C.
N1 - Funding Information:
This research was supported in part by U.S. Public Health Service Grant CA-02817 from the National Cancer Institute. Rick A. Finch is a Special Fellow of the Leukemia Society of America.
PY - 1999/6/15
Y1 - 1999/6/15
N2 - WEHI-3B D- cells differentiate in response to 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) but not to all-trans-retinoic acid (RA) or other inducing agents. Combinations of RA with 1,25-(OH)2D3 interact to produce synergistic differentiation of WEHI-3B D- cells. To determine factors involved in the synergistic interaction, expression of the 1,25-(OH)2D3 receptor (VDR) and retinoid receptors, RARα and RXRα, was measured. No VDR was detected in untreated WEHI-3B D- cells; however, RA and 1,25-(OH)2D3 when used as single agents caused a slight induction of the VDR and in combination produced a marked increase in the VDR. In contrast, no changes in RARα and RXRα were initiated by these compounds. An RAR-selective agonist combined with 1,25-(OH)2D3 produced synergistic differentiation of WEHI-3B D- cells, whereas an RXR-selective agonist did not. To gain information on the role of the VDR in the synergistic interaction, the VDR gene was transferred into WEHI-3B D+ cells, in which no VDR was detected and no synergism was produced. Expression of the VDR conferred differentiation responsiveness to 1,25-(OH)2D3 in WEHI-3B D+ cells. These findings suggest that (a) induction of VDR expression is a key component in the synergistic differentiation induced by 1,25-(OH)2D3 and RA and (b) RAR and not RXR must be activated for enhanced induction of the VDR and for the synergistic differentiation produced by RA and 1,25-(OH)2D3.
AB - WEHI-3B D- cells differentiate in response to 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) but not to all-trans-retinoic acid (RA) or other inducing agents. Combinations of RA with 1,25-(OH)2D3 interact to produce synergistic differentiation of WEHI-3B D- cells. To determine factors involved in the synergistic interaction, expression of the 1,25-(OH)2D3 receptor (VDR) and retinoid receptors, RARα and RXRα, was measured. No VDR was detected in untreated WEHI-3B D- cells; however, RA and 1,25-(OH)2D3 when used as single agents caused a slight induction of the VDR and in combination produced a marked increase in the VDR. In contrast, no changes in RARα and RXRα were initiated by these compounds. An RAR-selective agonist combined with 1,25-(OH)2D3 produced synergistic differentiation of WEHI-3B D- cells, whereas an RXR-selective agonist did not. To gain information on the role of the VDR in the synergistic interaction, the VDR gene was transferred into WEHI-3B D+ cells, in which no VDR was detected and no synergism was produced. Expression of the VDR conferred differentiation responsiveness to 1,25-(OH)2D3 in WEHI-3B D+ cells. These findings suggest that (a) induction of VDR expression is a key component in the synergistic differentiation induced by 1,25-(OH)2D3 and RA and (b) RAR and not RXR must be activated for enhanced induction of the VDR and for the synergistic differentiation produced by RA and 1,25-(OH)2D3.
KW - Differentiation
KW - RAR
KW - RXR
KW - Retinoic acid
KW - VDR
KW - Vitamin D
KW - WEHI-3B leukemia
UR - http://www.scopus.com/inward/record.url?scp=0033563316&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033563316&partnerID=8YFLogxK
U2 - 10.1006/excr.1999.4475
DO - 10.1006/excr.1999.4475
M3 - Article
C2 - 10366427
AN - SCOPUS:0033563316
SN - 0014-4827
VL - 249
SP - 279
EP - 290
JO - Experimental Cell Research
JF - Experimental Cell Research
IS - 2
ER -